Publications
Found 2 results
Filters: Keyword is Proto-Oncogene Proteins B-raf [Clear All Filters]
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.. Proc Natl Acad Sci U S A. 119(49):e2208900119.
.
2022. Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells.. Cell Syst. 11(5):478-494.e9.
.
2020.